Lymph Node Growth Rate in Testicular Germ Cell Tumours: Implications for Computed Tomography Surveillance Frequency

被引:2
作者
Mazrani, W. [2 ]
O'Malley, M. E. [1 ,2 ]
Chung, P. W. M. [1 ]
Warde, P. [1 ]
Vesprini, D. [3 ]
Panzarella, T. [4 ,5 ]
机构
[1] Univ Toronto, Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Joint Dept Med Imaging, Toronto, ON M5S 1A1, Canada
[3] Univ Toronto, Sunnybrook Odette Canc Ctr, Dept Radiat Oncol, Toronto, ON M5S 1A1, Canada
[4] Princess Margaret Hosp, Canc Program, Dept Biostat, Toronto, ON M5G 2M9, Canada
[5] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada
关键词
Computed tomography; growth rate; lymph node; surveillance; testicular cancer; TESTIS CANCER; SEMINOMA; GUIDELINES; MANAGEMENT; RELAPSE;
D O I
10.1016/j.clon.2010.10.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To estimate the growth rate of lymph nodes in patients on surveillance for testicular cancer who developed recurrent disease. Materials and methods: During a 7-year period, 318 patients at our institution were managed by surveillance and 39 relapsed (12.3%). The computed tomography scans of 28 patients (median age 32 years; range 19-51 years) who met our inclusion criteria and who developed recurrent disease in the abdomen/pelvis were retrospectively reviewed. Thirteen patients had non-seminoma and 15 had seminoma. To estimate the lymph node growth rate, the slope of lymph node size over time was calculated. Results: The median length of time from orchiectomy to the recurrence computed tomography was 131 days (range 49-520) or about 4.4 months for non-seminoma patients and 373 days (range 129-675) or about 12.3 months for seminoma patients. The median size of the involved lymph node at final computed tomography for seminoma patients was 12 mm (range 9-31 mm) and for non-seminoma patients was 15 mm (range 10-56 mm). The median lymph node growth rate for patients with seminoma was 1.35 mm/month (range 0.62-4.56) and for patients with non-seminoma 2.99 mm/month (range 0.77-7.06); the difference in growth rates was statistically significant (P = 0.029). Conclusions: There is a statistically significant faster growth rate of lymph nodes in patients with recurrent non-seminoma compared with patients with seminoma. This finding supports a more frequent computed tomography schedule during the first 2 years of surveillance in non-seminoma patients compared with seminoma patients. (C) 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:333 / 338
页数:6
相关论文
共 50 条
  • [21] Whole Body MRI in the Detection of Lymph Node Metastases in Patients with Testicular Germ Cell Cancer
    Pasoglou, Vassiliki
    Van Nieuwenhove, Sandy
    Van Damme, Julien
    Michoux, Nicolas
    Van Maanen, Aline
    Annet, Laurence
    Machiels, Jean-Pascal
    Tombal, Bertrand
    Lecouvet, Frederic E.
    LIFE-BASEL, 2022, 12 (02):
  • [22] Surveillance for stage I testicular germ cell tumours:: results and cost benefit analysis of management options
    Francis, R
    Bower, M
    Brunström, G
    Holden, L
    Newlands, ES
    Rustin, GJS
    Seckl, MJ
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (15) : 1925 - 1932
  • [23] Primary retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumours: outcomes and adjuvant chemotherapy
    Mousa, Ahmad
    Anson-Cartwright, Lynn
    Atenafu, Eshetu G.
    Jewett, Michael A. S.
    Bedard, Philippe
    Jiang, Di Maria
    Glicksman, Rachel
    Chung, Peter
    Warde, Padraig
    O'Malley, Martin
    Prendeville, Susan
    Hamilton, Robert J.
    BJU INTERNATIONAL, 2024, 134 (04) : 622 - 629
  • [24] Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights
    Looijenga, Leendert H. J.
    JOURNAL OF PATHOLOGY, 2009, 218 (02) : 146 - 162
  • [25] Frequency and Markers of Precursor Lesions and Implications for the Pathogenesis of Testicular Germ Cell Tumors
    von Eyben, Finn Edler
    Jensen, Marie Bjodstrup
    Hoyer, Soren
    CLINICAL GENITOURINARY CANCER, 2018, 16 (01) : E211 - E221
  • [26] Prediction of relapse after lymph node dissection for germ cell tumours: can salvage chemotherapy be avoided?
    D M Berney
    J Shamash
    W F Hendry
    A Arora
    S Jordan
    R T Oliver
    British Journal of Cancer, 2001, 84 : 340 - 343
  • [27] Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review
    Pierorazio, Phillip M.
    Cheaib, Joseph G.
    Patel, Hiten D.
    Gupta, Mohit
    Sharma, Ritu
    Zhang, Allen
    Tema, Giorgia
    Bass, Eric B.
    JOURNAL OF UROLOGY, 2021, 205 (02) : 370 - 382
  • [28] Prediction of relapse after lymph node dissection for germ cell tumours: can salvage chemotherapy be avoided?
    Berney, DM
    Shamash, J
    Hendry, WF
    Arora, A
    Jordan, S
    Oliver, RT
    BRITISH JOURNAL OF CANCER, 2001, 84 (03) : 340 - 343
  • [29] Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: evaluation of safety and efficacy
    Nicolai, Nicola
    Nazzani, Sebastiano
    Tesone, Antonio
    Macchi, Alberto
    Piva, Luigi
    Salvioni, Roberto
    Stagni, Silvia
    Torelli, Tullio
    Agostini, Edoardo
    Celso, Francesco
    Giannatempo, Patrizia
    Procopio, Giuseppe
    Avuzzi, Barbara
    Lanocita, Rodolfo
    Cattaneo, Laura
    Catanzaro, Mario
    Biasoni, Davide
    TUMORI JOURNAL, 2023, 109 (04): : 379 - 386
  • [30] Retroperitoneal lymph node dissection after chemotherapy for germ cell tumours: is a full bilateral template always necessary?
    Steiner, Hannes
    Peschel, Reinhard
    Bartsch, Georg
    BJU INTERNATIONAL, 2008, 102 (03) : 310 - 314